发明名称 ТЕРАПИЯ, НАПРАВЛЕННАЯ ПРОТИВ АНТИГЕНОВ Erb
摘要 A conjugate comprising a) a trifunctional cross-linking moiety, to which is coupled b) an affinity ligand via a linker 1, c) a cytotoxic agent, optionally via a linker 2, and d) an anti Erb antibody or variants thereof having the ability to bind to Erb antigens expressed on mammalian tumour surfaces with an affinity-binding constant of at least 5x10<SUP>6 </SUP>M<SUP>-1</SUP>, wherein the affinity ligand is biotin, or a biotin derivative having essentially the same binding function to avidin or streptavidin as biotin, wherein stability towards enzymatic cleavage of the biotinamide bond has been introduced in linker 1.
申请公布号 RU2006122952(A) 申请公布日期 2008.01.10
申请号 RU20060122952 申请日期 2004.11.26
申请人 МИТРА МЕДИКАЛ АБ (SE) 发明人 САНДБЕРГ Бенгт Э.Б. (SE);НИЛЬССОН Руне (SE)
分类号 A61K39/395;A61K51/10;C07K16/32;G01N33/574 主分类号 A61K39/395
代理机构 代理人
主权项
地址